ASCEND BY NTHRYS
Research Abroad Products

Personalized Medicine Project Topics

Browse all focused areas across all project categories under this field.

Showing 97–108 of 200 project topics
Predictive Analytics Dashboard for Pharmacy Benefit Management
A business intelligence platform that analyzes pharmacogenomic data across patient populations to identify medication optimization opportunities and prevent costly adverse events. PBMs, insurers, and health plans purchase annual licenses to reduce pharmacy spend by 15-25% through smarter formulary management.
Pharmacogenomics Commercial Platform Dev Click to view more details →
Genetic Testing Laboratory Information Management System
A comprehensive LIMS solution designed specifically for pharmacogenomics laboratories to manage sample workflows, quality control, and regulatory compliance across high-throughput testing. Clinical labs and diagnostic companies license this software to improve operational efficiency, reduce turnaround time, and maintain CAP and CLIA accreditation.
Pharmacogenomics Commercial Platform Dev Click to view more details →
Clinician Decision Support Tool for Precision Dosing Algorithms
A web-based clinical tool that integrates patient genetics, age, renal function, and drug interactions to recommend individualized medication doses at the point of prescribing. Healthcare systems license this platform to improve medication safety, reduce adverse events, and demonstrate measurable ROI through reduced hospitalizations.
Pharmacogenomics Commercial Platform Dev Click to view more details →
Pharmacogenomic Data Analytics and Reporting SaaS for Manufacturers
A enterprise SaaS platform that aggregates real-world pharmacogenomic and outcome data, enabling pharmaceutical manufacturers to understand drug performance across genetic subpopulations. Drug companies license this analytics suite to support post-market surveillance, identify high-responder populations, and guide precision medicine marketing strategies.
Pharmacogenomics Commercial Platform Dev Click to view more details →
Real-time Circulating Tumor DNA Analytics Platform
A cloud-based SaaS platform that processes and analyzes circulating tumor DNA (ctDNA) sequencing data in real-time to detect cancer mutations and monitor treatment response. Enables oncology clinics to offer personalized treatment recommendations and early detection services, creating recurring revenue through per-test analysis fees and licensing agreements.
Liquid Biopsy Personalized Medicine Dev Click to view more details →
Liquid Biopsy Sample Collection Kit Subscription Service
A direct-to-consumer subscription service delivering pre-packaged, clinically-validated blood draw kits optimized for circulating biomarker detection and home-based sample collection. Generates revenue through monthly subscription fees, sample processing charges, and partnerships with telehealth providers and insurance companies for preventive screening programs.
Liquid Biopsy Personalized Medicine Dev Click to view more details →
Multi-Biomarker Fusion Detection Engine Software
An AI-powered software tool that simultaneously detects multiple liquid biopsy biomarkers including ctDNA, circulating tumor cells, and exosomes from a single blood sample. Monetizes through white-label licensing to diagnostic labs, pharmaceutical companies conducting clinical trials, and healthcare systems implementing precision oncology programs.
Liquid Biopsy Personalized Medicine Dev Click to view more details →
Personalized Cancer Risk Stratification Dashboard
An interactive clinical dashboard that aggregates liquid biopsy results with patient genetics, lifestyle data, and imaging to generate personalized cancer risk scores and monitoring protocols. Delivers value through B2B sales to hospital networks, insurance providers seeking risk-based pricing models, and direct-to-consumer wellness platforms.
Liquid Biopsy Personalized Medicine Dev Click to view more details →
Minimal Residual Disease Monitoring Mobile Application
A mobile app that enables cancer patients to track minimal residual disease (MRD) status through regular liquid biopsy testing and visualize treatment response trends in real-time. Generates revenue through per-patient monthly subscriptions, integration fees with oncology EHR systems, and data licensing agreements with pharmaceutical companies.
Liquid Biopsy Personalized Medicine Dev Click to view more details →
Automated Liquid Biopsy Workflow Management System
An enterprise workflow automation platform that streamlines sample collection, transportation, laboratory processing, and result reporting for high-volume liquid biopsy testing operations. Creates revenue through SaaS licensing fees, implementation services for diagnostic laboratories, and transaction-based pricing tied to test volume.
Liquid Biopsy Personalized Medicine Dev Click to view more details →
Predictive Treatment Response Platform Using Liquid Biomarkers
A predictive analytics platform that uses machine learning models trained on liquid biopsy data to forecast immunotherapy and targeted therapy response before treatment initiation. Monetizes through licensing to pharmaceutical manufacturers for clinical trial enrichment, hospital systems for treatment selection, and data partnerships with research institutions.
Liquid Biopsy Personalized Medicine Dev Click to view more details →
Non-Invasive Residual Cancer Burden Assessment Tool
A specialized software tool that quantifies residual cancer burden post-surgery or chemotherapy using ctDNA and protein biomarker analysis from routine blood draws. Delivers business value through licensing to surgical oncology centers, integration with cancer registry systems, and partnership programs with pharmaceutical companies monitoring adjuvant therapy outcomes.
Liquid Biopsy Personalized Medicine Dev Click to view more details →